Five year follow up of a patient with spinal and bulbar muscular atrophy treated with leuprorelin

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 75, Issue 8, 2004, Pages 1206-1207

  Shimohata, T ^a   Kimura, T ^a   Nishizawa, M ^a   Onodera, O ^a   Tsuji, S ^b  

^a NIIGATA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; CREATININE; LEUPRORELIN; LUTEINIZING HORMONE; TESTOSTERONE;

AGED; ARTICLE; BABINSKI REFLEX; CASE REPORT; CREATININE BLOOD LEVEL; DISEASE EXACERBATION; DRUG EFFICACY; FINGER; FOLLOW UP; GAIT DISORDER; GENETIC ANALYSIS; GYNECOMASTIA; HUMAN; KENNEDY DISEASE; LABORATORY TEST; MALE; MOTOR PERFORMANCE; MUSCLE STRENGTH; MUSCLE WEAKNESS; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; PROSTATE CANCER; TENDON REFLEX; TREATMENT OUTCOME; TREMOR;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; HUMANS; LEUPROLIDE; MALE; MUSCULAR DISORDERS, ATROPHIC; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 3442900885     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2003.030064     Document Type: Article

References (5)

1. La Spada AR, Wilson EM, Lubahn DB, et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991;352:77-9.
2. Katsuno M, Adachi H, Doyu M, et al. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat Med 2003;9:768-73.
3. Katsuno M, Adachi H, Kume A, et al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 2002;35:843-54.
4. Takeyama K, Ito S, Yamamoto A, et al. Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila. Neuron 2002;35:855-64.
5. Garnick MB, Fair W. Combating prostate cancer. Sci Am 1998;279:74-83.